ArticleQuantitative imaging in medicine and surgery2025
Early identification of abnormal pulmonary infectious diseases using unsupervised anomaly detection.
Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The early identification of abnormal pulmonary infectious diseases (APIDs) could effectively control the large-scale spread of such diseases. This study proposed a deep learning-based method for the early identification of APIDs. Methods: Unsupervised anomaly detection (UAD) refers to the identification of abnormal samples of which its distribution differs from that of normal samples using a training set comprised of only normal samples. Building on this principle, we proposed a method for the early identification of APIDs. First, we established a pulmonary infection computed tomography (PICT) image sequence dataset, which included computed tomography (CT) image sequences of various common pulmonary infections, as well as two known abnormal cases [coronavirus disease 2019 (COVID-19) and melioidosis pneumonia]. Under our framework, only common infection sequences were used to train the UAD network, while both common and abnormal sequences were used in testing to assess the capability of the network to identify deviations. This approach not only detected the two known abnormal cases but was also able to detect unknown APIDs. To enhance the detection accuracy (ACC) of our approach, we developed the local reconstruction autoencoder (LRAE), which focuses on local regions in PICT images to effectively distinguish between common and abnormal infection areas. Results: Comprehensive experiments on the PICT dataset were conducted using metrics such as the area under the curve (AUC), F1-score, and ACC, and the results revealed the effectiveness and superiority of the LRAE compared to existing UAD methods. Specifically, the AUC, F1-score, and ACC of the LRAE in detecting COVID-19 CT image sequences were 0.8269, 0.7242, and 0.7801, respectively; while those for the melioidosis pneumonia CT image sequences were 0.8716, 0.6415, and 0.8146, respectively. Conclusions: This work offers a robust solution for the early identification of both known and emerging APIDs. The developed LRAE showed remarkable performance in detecting abnormal PICT image sequences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.